All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention Dr. Robert Pierce, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Kristi Jones
All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention Dr. Robert Pierce, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window. The average consequence score is 6, matching the 6 beat baseline for this window. Kristi Jones appears in 1 tracked Healthcare story from July 27, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Kristi Jones. Shared-story counts are live from our verified record — not editorial picks.
Lupin’s creation of Kaveri Therapeutics, a U.S. oncology biotech housing two early-stage programs with positive ASCO data, signals a shift toward decentralized R&D models. The spin-out could accelerate the development of targeted cancer treatments and expand options for patients.